// IP Marketing video - START// IP Marketing video - END

Drugs giant Novartis posts $2.08 billion Q4 net profit

Drugs giant Novartis posts $2.08 billion Q4 net profit

PanARMENIAN.Net - Swiss drug maker Novartis AG has reported a fourth-quarter net profit of $2.08 billion, AP said.

The result is 72 percent higher than the $1.21 billion net profit reported for the last quarter of 2011 when the Basel-based company took a $900-million after ending its clinical study into wider uses of the hypertension drug Tekturna.

Novartis said Wednesday, January 23 that fourth-quarter sales in 2012 were almost flat at $14.83 billion compared with $14.78 billion in the same period the previous year.

The company also said that long-time chairman and former chief executive Daniel Vasella will leave the board at the next shareholders' meeting at the end of February.

 Top stories
At a meeting with representatives of the tourism industry, Karayan said the sector is capable of creating inclusive added value.
The first stage of work on extending the life of Metsamor NPP for another 10 years until 2026 has also been performed.
This operation will help improve the country’s competitiveness and business environment, said World Bank Country Manager for Armenia.
The financing will be directed to energy efficiency, renewable energy, agribusiness, food processing, education and healthcare projects.
Partner news